Incidence and Outcome of Chronic Graft-versus-Host Disease Using National Institutes of Health Consensus Criteria

Biology of Blood and Marrow Transplantation

Volumn 13, Issue 10, 2007, Pages 1207-1215

  Jagasia, Madan ^a   Giglia, Jennifer ^a   Chinratanalab, Wichai ^a,b   Dixon, Sheri ^a   Chen, Heidi ^a   Frangoul, Haydar ^a   Engelhardt, Brian ^a   Goodman, Stacey ^a,b   Greer, John ^a   Kassim, Adetola ^a   Morgan, David ^a   Ruffner, Katherine ^a,b   Schuening, Friedrich ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Chronic GVHD; Grading; NIH consensus criteria

Indexed keywords

BUSULFAN; CALCINEURIN INHIBITOR; CARMUSTINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETOPOSIDE; FLUDARABINE; FOSCARNET; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CANCER SURVIVAL; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; COHORT ANALYSIS; CONSENSUS DEVELOPMENT; CYTOMEGALOVIRUS INFECTION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; FEMALE; HAZARD RATIO; HEALTH CARE ORGANIZATION; HEMATOLOGIC MALIGNANCY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MYELOABLATIVE CONDITIONING; NONMYELOABLATIVE CONDITIONING; OUTCOMES RESEARCH; OVERALL SURVIVAL; PREDICTION; REDUCED INTENSITY CONDITIONING; SURVIVAL TIME; UNIVARIATE ANALYSIS; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; COHORT STUDIES; FEMALE; GRAFT VS HOST DISEASE; HUMANS; INCIDENCE; INFANT; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NATIONAL INSTITUTES OF HEALTH (U.S.); PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TENNESSEE; UNITED STATES;

EID: 34548663895     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2007.07.001     Document Type: Article

References (17)

1. Sullivan K. Graft vs. host disease. In: Blume K.G., Forman S.J., and Appelbaum F. (Eds). Thomas' Hematopoietic Cell Transplantation (2006), Blackwell Publishing, Oxford, UK 635-664
2. Sullivan K.M., Witherspoon R.P., Storb R., et al. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease. Blood 72 (1988) 555-561
3. Shulman H.M., Sullivan K.M., Weiden P.L., et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 69 (1980) 204-217
4. Lee S.J., Vogelsang G., and Flowers M.E. Chronic graft-versus-host disease. Biol Blood Marrow Transplant 9 (2003) 215-233
5. Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 11 (2005) 945-956
6. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18 (1974) 295-304
7. Heinze G., and Schemper M. A solution to the problem of monotone likelihood in Cox regression. Biometrics 57 (2001) 114-119
8. Gray R.J. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16 (1988) 1141-1154
9. Gooley T.A., Leisenring W., Crowley J., and Storer B.E. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18 (1999) 695-706
10. Mielcarek M., Martin P.J., Leisenring W., et al. Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood 102 (2003) 756-762
11. Flowers M.E., Parker P.M., Johnston L.J., et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood 100 (2002) 415-419
12. Storb R., Prentice R.L., Sullivan K.M., et al. Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. Ann Intern Med 98 (1983) 461-466
13. Niederwieser D., Pepe M., Storb R., et al. Factors predicting chronic graft-versus-host disease and survival after marrow transplantation for aplastic anemia. Bone Marrow Transplant 4 (1989) 151-156
14. Atkinson K., Horowitz M.M., Gale R.P., et al. Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood 75 (1990) 2459-2464
15. Ochs L.A., Miller W.J., Filipovich A.H., et al. Predictive factors for chronic graft-versus-host disease after histocompatible sibling donor bone marrow transplantation. Bone Marrow Transplant 13 (1994) 455-460
16. Carlens S., Ringden O., Remberger M., et al. Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis. Bone Marrow Transplant 22 (1998) 755-761
17. Lee S.J., Klein J.P., Barrett A.J., et al. Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood 100 (2002) 406-414